In breast cancer patients with high expression of IDO1/TDO2, low expression of KYNU was associated with a higher degree of tumor infiltration and lymphatic infiltration, whereas high expression of KYNU was significantly associated with a better level of prognosis in the patients. The gene discussed is IDO1; the disease is breast cancer.